• Cat-intel
  • MedIntelliX
  • Resources
  • About Us
  • Rheumatic Fever Companies

    ID: MRFR/Pharma/4849-HCR
    100 Pages
    Rahul Gotadki
    September 2025

    Rheumatic fever companies focus on providing medical solutions for individuals affected by rheumatic fever, an inflammatory condition that can result from untreated streptococcal infections. These companies contribute to cardiology and infectious disease management by offering antibiotics, anti-inflammatory medications, and supportive care for rheumatic fever.

    Share:
    Download PDF ×

    We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

    Top Industry Leaders in the Rheumatic Fever Market

    Rheumatic Fever Key Companies

    Latest Rheumatic Fever Companies Update


    Pfizer and Abbott Laboratories pharmaceutical giants continue to dominate the antibiotic market, including those used to treat GAS infections, potentially benefiting from increased awareness and treatment initiatives for rheumatic fever.


    Johnson & Johnson Another major player in the antibiotics market, J&J's involvement could also be impacted by increased focus on rheumatic fever prevention and treatment.


    Smaller Biotechs Companies like Rheumatic Fever Therapeutics are emerging with innovative approaches, like developing anti-inflammatory medications specifically targeting rheumatic fever, potentially disrupting the traditional treatment landscape.


    List of Rheumatic Fever Key Companies in the Market



    • Bayer AG

    • Abbott Laboratories

    • Johnson & Johnson Services, Inc.

    • Hoffmann-La Roche Ltd.

    • Novartis AG

    • Pfizer, Inc.

    • AstraZeneca

    • Valeant Pharmaceuticals International, Inc.

    • Eli Lily and Company

    • Bristol-Myers Squibb Company